| 12391945 |
Coronavirus IRNA compositions and methods of use thereof |
James D. McIninch, Yesseinia Anglero-Rodriguez, Mark K. Schlegel, Christy M. Hebner, Florian A. Lempp |
2025-08-19 |
| 12364762 |
Biodegradable lipids for the delivery of active agents |
Martin Maier, Muthusamy Jayaraman, Shigeo Matsuda, Pachamuthu Kandasamy, Kallanthottathil G. Rajeev +3 more |
2025-07-22 |
| 12350338 |
Biodegradable lipids for the delivery of active agents |
Martin Maier, Muthusamy Jayaraman, Shigeo Matsuda, Pachamuthu Kandasamy, Kallanthottathil G. Rajeev +3 more |
2025-07-08 |
| 12343398 |
Biodegradable lipids for the delivery of active agents |
Martin Maier, Muthusamy Jayaraman, Shigeo Matsuda, Pachamuthu Kandasamy, Kallanthottathil G. Rajeev +3 more |
2025-07-01 |
| 12338439 |
Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof |
Gregory Hinkle, Martin Maier, James Butler, Jingxuan Liu |
2025-06-24 |
| 12239709 |
Biodegradable lipids for the delivery of active agents |
Martin Maier, Muthusamy Jayaraman, Shigeo Matsuda, Pachamuthu Kandasamy, Kallanthottathil G. Rajeev +3 more |
2025-03-04 |
| 12241064 |
REVERSIR™ compounds |
Vasant Jadhav, John M. Maraganore, Martin Maier, Kallanthottathil G. Rajeev, Muthiah Manoharan +1 more |
2025-03-04 |
| 12221607 |
Multi-targeted single entity conjugates |
Vasant Jadhav, Martin Maier, Ivan Zlatev, Kallanthottathil G. Rajeev, Jayaprakash K. Nair +2 more |
2025-02-11 |